This content is in French.
ESMO Virtual Plenaries 2021
15 Juillet 2021 · 2 joursOnline, SwissOncologyEnglish
OnlineAbout this congress
KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC
Videos from this congress

Play the video · ESMO Virtual Plenaries 2021Free registration required to play
00:01:49